IBM and MDS in proteomics deal

IBM and MDS Proteomics, a subsidiary of MDS (TSE:MDS; MDZ), will collaborate to

Read the full 131 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE